Louise Kooij
Comptroller/Controller/Auditor bij FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Vermogen: - $ op 31-05-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Michael Davidson | M | 67 | 2 jaar | |
| Sander Slootweg | M | - | - | |
| Janneke van der Kamp | F | 49 | 1 jaar | |
| Bob Rambo | M | - | 1 jaar | |
| James Jacobson | M | - | 2 jaar | |
| Stefano Portolano | M | - |
Azafaros BV
 Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | 3 jaar |
| John Kastelein | M | 70 | 2 jaar | |
| Juliette Audet | F | 38 | 2 jaar | |
| John Smither | M | 71 | 1 jaar | |
| Douglas Kling | M | 50 | 3 jaar | |
| Louis Lange | M | 72 | 2 jaar | |
| Nicholas Downing | M | 39 | 2 jaar | |
| Marc Ditmarsch | M | 58 | 4 jaar | |
| Will Lewis | M | 55 | - | |
| Mayur Ian Somaiya | M | 50 | 1 jaar | |
| Annie Neild | F | - | 3 jaar | |
| Silvia Ragno | M | - |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | 1 jaar |
| James Topper | M | 62 | 2 jaar | |
| William Jones | M | 60 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Olivier Morand | M | - |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | - |
| Jennifer Chien | F | 49 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 6 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Nederland | 20 | 95.24% |
| Verenigd Koninkrijk | 1 | 4.76% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Louise Kooij
- Persoonlijk netwerk
